Terug
Dagbereik
€ 1.217,53
€ 1.272,21
52-Weeksbereik
€ 946,69
€ 1.525,17
Volume
111.962
50D / 200D Gem.
€ 1.353,91
/
€ 1.321,41
Vorige Slotkoers
€ 1.239,07
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 29,7 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | 21,6 | 3,8 |
| Rev Growth 5Y % | 2,0 | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 1.485,00
+17.4%
Low: € 1.400,00
High: € 1.600,00
Forward K/W
26,7
Forward WPA
€ 46,50
WPA Groei (sch.)
+0,0%
Omzet Sch.
4,2 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 68,32
€ 67,48 – € 68,97
|
5,1 B | 1 |
| FY2029 |
€ 62,62
€ 61,84 – € 63,22
|
4,9 B | 1 |
| FY2028 |
€ 56,93
€ 56,06 – € 57,87
|
4,7 B | 3 |
Belangrijkste Punten
Revenue grew 2,01% annually over 5 years — modest growth
Net margin of 21,59% shows strong profitability
Generating 848,65M in free cash flow
Cash machine — converts 97,64% of earnings into free cash flow
Capital efficient — spends only 2,66% of revenue on capex
ROIC of 36,16% — excellent capital efficiency
Groei
Revenue Growth (5Y)
2,01%
Revenue (1Y)3,98%
Earnings (1Y)0,70%
FCF Growth (3Y)-0,69%
Kwaliteit
Return on Equity
N/A
ROIC36,16%
Net Margin21,59%
Op. Margin27,78%
Veiligheid
Debt / Equity
N/A
Current Ratio1,14
Interest Coverage16,32
Waardering
P/E Ratio
29,72
P/B RatioN/A
EV/EBITDA25,13
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,98% | Revenue Growth (3Y) | 3,09% |
| Earnings Growth (1Y) | 0,70% | Earnings Growth (3Y) | 4,97% |
| Revenue Growth (5Y) | 2,01% | Earnings Growth (5Y) | 3,11% |
| Profitability | |||
| Revenue (TTM) | 4,03B | Net Income (TTM) | 869,19M |
| ROE | N/A | ROA | 23,41% |
| Gross Margin | 57,52% | Operating Margin | 27,78% |
| Net Margin | 21,59% | Free Cash Flow (TTM) | 848,65M |
| ROIC | 36,16% | FCF Growth (3Y) | -0,69% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,14 |
| Interest Coverage | 16,32 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 29,72 | P/B Ratio | N/A |
| P/S Ratio | 6,42 | PEG Ratio | 8,96 |
| EV/EBITDA | 25,13 | Dividend Yield | 0,00% |
| Market Cap | 25,83B | Enterprise Value | 28,11B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,03B | 3,87B | 3,79B | 3,92B | 3,72B |
| Net Income | 869,19M | 863,14M | 788,78M | 872,50M | 768,99M |
| EPS (Diluted) | 42,17 | 40,67 | 35,90 | 38,41 | 32,78 |
| Gross Profit | 2,32B | 2,25B | 2,17B | 2,24B | 2,11B |
| Operating Income | 1,12B | 1,13B | 1,08B | 1,13B | 994,74M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,71B | 3,24B | 3,36B | 3,49B | 3,33B |
| Total Liabilities | 3,74B | 3,37B | 3,51B | 3,47B | 3,16B |
| Shareholders' Equity | -23,64M | -126,89M | -149,94M | 24,79M | 171,42M |
| Total Debt | 2,34B | 2,13B | 2,20B | 2,13B | 1,80B |
| Cash & Equivalents | 66,89M | 59,36M | 69,81M | 95,97M | 98,56M |
| Current Assets | 1,36B | 1,19B | 1,23B | 1,38B | 1,27B |
| Current Liabilities | 1,20B | 1,17B | 1,18B | 1,15B | 1,15B |